Metformin decreases angiogenesis via NF-κB and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin-1

Bee K. Tan(University of Warwick), Harpal Randeva(University of Warwick)
Cardiovascular Research
May 4, 2009
Cited by 115


Related Papers